Global Bovine Mastitis Treatment Market to Reach $2.3 Billion by 2030

Bovine mastitis, a common and costly disease in dairy farming, can severely impact milk production and herd health. 

The growing integration of real-time diagnostic technologies and farm management software is a key innovation driving the functionality of bovine mastitis treatment systems. These systems enable farmers to monitor the health of each cow, track treatment outcomes, and make informed decisions to optimize herd management. The emphasis on reducing antibiotic use and enhancing animal welfare is also driving demand for these technologies, aligning with the global push for sustainable farming practices.

Early detection and targeted treatment minimize disease severity, ensuring that cows receive timely care and produce higher-quality milk. These systems also support ethical farming practices by reducing pain and discomfort for cows, contributing to a healthier and more productive herd.

Key market drivers include the increasing adoption of precision farming, awareness of antibiotic resistance, and a growing focus on sustainable agriculture. The U.S. market, valued at $490.9 million in 2023, remains a leading region, while China is expected to grow at a 7.0% CAGR to reach $484.4 million by 2030. Other regions such as Japan, Canada, and Germany also show significant growth potential.